Q3 2021 · —
Revenue—
Net Income-$16.41M-$16.41M no prior Q3 2020 on fileN/M vs Q2 2021
EPS Diluted-$1.52-$1.52 no prior Q3 2020 on fileno prior Q2 2021 on file
Operating Income-$10,427,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q3 2020 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prime Medicine, Inc. · CIK 1894562 · Engraved from SEC EDGAR